The potential combination of Bayer (BAYRY) and Monsanto (MON) could be blocked, said TheStreet's Jim Cramer. He said the overlap in the two companies' seed businesses could spur the already very zealous anti-trust regulators to stop a potential deal.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.